FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma

Title
FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
Authors
Keywords
-
Journal
Aging-US
Volume -, Issue -, Pages -
Publisher
Impact Journals, LLC
Online
2021-03-04
DOI
10.18632/aging.202625

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started